Cite
HARVARD Citation
Emery, P. et al. (n.d.). AB0780 Secukinumab sustains individual clinical responses over time in patients with psoriatic arthritis: 2-year results from a phase 3 trial, future 2. Annals of the rheumatic diseases. p. 1329. [Online].